This 'sleeper' is going to wake 'bigtime' when the VNDA royalties start rolling in later this year (the $1.50+ estimates should pail in comparison---imo). To further their gains, I hope they were able to get the patent extension they applied for. There is a 'big' need for effective bi-polar treatments & TTNP's 'Fanapt' will go a long way in filling that need. As I recall , TTNP had another drug in late stage testing as well....don't know the details on that one.....may be more to come.